Tag: Stability indicating methods

Using Forced Degradation to Predict Long-Term Stability

Forced degradation, or stress testing, is a critical tool in the pharmaceutical stability arsenal. By intentionally subjecting drug substances and products to extreme conditions, manufacturers can identify potential degradation pathways, validate stability-indicating methods, and predict long-term stability profiles. These studies not only support regulatory expectations per ICH Q1A(R2) but also accelerate product development. This tutorial…

Factors Affecting Drug Shelf Life (Storage Conditions, Container, Light, etc.), Shelf Life and Expiry

Using Design of Experiments (DoE) for Stability Optimization

Design of Experiments (DoE) is a cornerstone of Quality by Design (QbD), empowering pharmaceutical scientists to evaluate how multiple variables affect product performance. When applied to stability studies, DoE enables a more systematic, data-driven approach to identifying key factors that influence shelf-life, degradation pathways, and long-term drug quality. 🎯 Why Use DoE in Stability Testing?…

Pharmaceutical Quality and Practices, Quality by Design (QbD) in Stability Testing

Differences in Protocol Design for Small Molecule vs. Biologic Drugs

Stability protocols for pharmaceutical products are not one-size-fits-all. Regulatory expectations, degradation pathways, storage requirements, and testing methods vary significantly between small molecule drugs and biologics. Designing a protocol that accounts for these nuances is essential to ensure product integrity, patient safety, and regulatory compliance. In this tutorial, we compare and contrast protocol design strategies for…

Protocols and Reports, Stability Study Protocols for Different Drug Types

Validate Forced Degradation Methods to Confirm Stability-Indicating Capability

Understanding the Tip: What are forced degradation studies and why they matter: Forced degradation involves subjecting a drug substance or product to extreme stress conditions—such as heat, light, pH, oxidation, or humidity—to accelerate the breakdown of the molecule. These studies help identify likely degradation products and ensure that the analytical method can detect and quantify…

Stability Study Tips

Stability Studies for Active Pharmaceutical Ingredients (APIs)

Stability Studies for APIs

Understanding Degradation Mechanisms in API Stability Testing

Understanding Degradation Mechanisms in API Stability Testing Comprehensive Analysis of Drug Degradation Pathways in API Stability Introduction Maintaining the stability of active pharmaceutical ingredients (APIs) throughout their lifecycle is essential for ensuring drug safety, efficacy, and regulatory compliance. A critical aspect of stability science involves understanding the degradation pathways by which APIs undergo chemical and…

Drug Degradation Pathways in API Stability, Stability Studies for APIs

Stability Protocol Design for Biosimilar Comparability

Stability Protocol Design for Biosimilar Comparability How to Design Stability Testing Protocols for Biosimilar Comparability Assessments Biosimilars are not generic copies of biologics; rather, they are highly similar versions of approved reference products with no clinically meaningful differences in terms of safety, purity, or potency. Demonstrating stability comparability is a cornerstone of biosimilar development. This…

Stability Testing for Biopharmaceuticals, Stability Testing Types

Evaluating the Influence of Impurities on API Stability Profiles

Evaluating the Influence of Impurities on API Stability Profiles Assessing the Impact of Impurities on the Stability of Active Pharmaceutical Ingredients Introduction The presence, formation, and behavior of impurities play a critical role in the stability of Active Pharmaceutical Ingredients (APIs). Impurities can originate from various sources—including synthesis by-products, degradation processes, residual solvents, or packaging…

Impact of Impurities on API Stability Data, Stability Studies for APIs

Aggregation Pathways and Biologic Stability Challenges

Aggregation Pathways and Biologic Stability Challenges Understanding Aggregation Pathways and Overcoming Stability Challenges in Biopharmaceuticals Aggregation is one of the most common and critical stability issues in biopharmaceuticals. Protein-based drugs are inherently prone to physical degradation, and aggregation can severely impact product quality, safety, and efficacy. This tutorial provides a step-by-step overview of aggregation pathways,…

Stability Testing for Biopharmaceuticals, Stability Testing Types

Analytical Tools for Stability Testing in Pharmaceuticals

Analytical Techniques in Stability Studies